The magic forest: novel radiotracers on their way to clinical translation
Lena Unterrainer, Munich / Germany
1. To know about the challenges of clinical tracer development.
2. To discuss a range of novel radiotracers with high translational potential and their potential clinical benefits.
3. To embrace an example of a once-promising radiotracer that got stuck in the pipeline, never made it and why?